Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Bjpsych Open|July 31, 2026
Multidimensional moderators of treatment trajectories in people with schizophrenia at high risk of relapse: findings from a real-world lower middle-income country cohortRetha Smit, Hilmar Luckhoff, Lebogang Phahladira, et al.
Frontiers in Genetics|July 30, 2019
The Potential Role of Regulatory Genes (DNMT3A, HDAC5, and HDAC9) in Antipsychotic Treatment Response in South African Schizophrenia PatientsKevin Sean O'Connell, Nathaniel Wade McGregor, Robin Emsley, et al.
Social Psychiatry and Psychiatric Epidemiology|September 13, 2022
The 3-year progression of clinically significant psychotic-like experiences in a general adult population in Lagos, NigeriaAbiodun O Adewuya, Olabisi E Oladipo, Tomilola Imarah, et al.
Plos One|June 3, 2015
Instruments measuring blunted affect in schizophrenia: a systematic reviewSanja Kilian, Laila Asmal, Anneke Goosen, et al.
Molecular and Cellular Neurosciences|March 6, 2018
The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorderKevin S O'Connell, Nathaniel W McGregor, Christine Lochner, et al.
Cognitive Neuropsychiatry|December 3, 2008
Allocation of attention to the eye and mouth region of faces in schizophrenia patientsJukka M Leppänen, Dana J H Niehaus, Liezl Koen, et al.
Metabolic Brain Disease|December 8, 2011
Alcohol-induced psychotic disorder: brain perfusion and psychopathology--before and after anti-psychotic treatmentGerhard P Jordaan, James M Warwick, Daan G Nel, et al.
Schizophrenia Research|November 27, 2019
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophreniaRobin Emsley, Laila Asmal, Jose M Rubio, et al.
Early Intervention in Psychiatry|August 31, 2016
Symptom attribution and frontal cortical thickness in first-episode schizophreniaLaila Asmal, Stefan du Plessis, Matthijs Vink, et al.
The Journal of Clinical Psychiatry|May 15, 2012
Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical studyRobin Emsley, Petrus P Oosthuizen, Liezl Koen, et al.
Pageof 15